Francisco Castillo, MD
Ophthalmic Plastic and Reconstructive Surgery · Portland, ORNPI 1831320233
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $54,854 of the $58,898 with a category attached, or 93.1%. Amgen accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $19,691 and has fallen 99.2% since, to $154 in 2025.
Across 100 payments — averaging $588.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$59K
- Alcon$31
- Vertex$27
What the payments were for
- Speaking & faculty fees$54,85493%
- Travel & lodging$2,5994%
- Food & beverage$1,4462%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$56,382
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 550 | $6,965 |
| Prednisolone Acetate | 133 | $6,908 |
| Cyclosporine | 19 | $3,549 |
| Latanoprost | 39 | $455 |
| ValacyclovirValacyclovir Hcl | 29 | $449 |
| Methylprednisolone | 53 | $414 |
| Fluticasone Propionate | 22 | $349 |
| Scopolamine | 23 | $310 |
| ErythromycinErythromycin Base | 18 | $266 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $211 |
| Dexamethasone | 12 | $145 |
| Dorzolamide Hcl | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Portland
- Roger DaileyPortland$138K
- Davin AshrafPortland$9K
- Natalie HoeslyPortland$2K
- Prashanth VallabhanathPortland$1K
- John NgPortland$400
- Eric SteelePortland$24
- Blake FausettEugene$40K
- Vivian SchiedlerAshland$4K
- Tara GoecksBend$2K
- Elizabeth EchalierMedford$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.